Sheehan Jeannine
Known title: Chief Administrative OfficerCIK: 0001775188
Associated companies
Transaction History
| INFU | ▼ Sell | Tax Withholding | 4,435 | $38K | 5/20/2022 | View on chart |
| INFU | ▼ Sell | Tax Withholding | 2,085 | $18K | 5/20/2022 | View on chart |
| INFU | ▲ Buy | Grant | 4,700 | $0 | 5/20/2022 | View on chart |
| INFU | ▲ Buy | Grant | 10,000 | $0 | 5/20/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 2,821 | $0 | 5/18/2022 | View on chart |
| INFU | ▼ Sell | Tax Withholding | 1,252 | $11K | 5/18/2022 | View on chart |
| INFU | ▲ Buy | Grant | 9,744 | $0 | 5/18/2022 | View on chart |
| INFU | ▼ Sell | Tax Withholding | 4,419 | $37K | 5/18/2022 | View on chart |
| INFU | ▲ Buy | Option Exercise | 6,943 | $31K | 12/31/2021 | View on chart |
| INFU | ▼ Sell | Open Market | 6,943 | $118K | 12/31/2021 | View on chart |
| INFU | ▲ Buy | Option Exercise | 1,000 | $4K | 12/30/2021 | View on chart |
| INFU | ▼ Sell | Open Market | 1,000 | $17K | 12/30/2021 | View on chart |
| INFU | ▲ Buy | Option Exercise | 7,461 | $33K | 11/24/2021 | View on chart |
| INFU | ▼ Sell | Open Market | 7,461 | $134K | 11/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
INFU Shares Business Overview, Emphasizes Patient-First Strategy
INFU held a discussion outlining its business model and growth plans, highlighting a patient‑first approach to its services. The company emphasized expanding its product portfolio and improving customer engagement. The talk comes as the stock is near a key support level and shows moderate momentum. Analysts see upside potential, with a target range of $15‑$18.
INFU Shares Business Overview, Emphasizes Patient-First Strategy. INFU held a discussion outlining its business model and growth plans, highlighting a patient‑first approach to its services. The company emphasized expanding its product portfolio and improving customer engagement. The talk comes as the stock is near a key support level and shows moderate momentum. Analysts see upside potential, with a target range of $15‑$18.